FDA Warns of Cybersecurity Risk With Certain Medtronic Insulin Pumps
Equipment issue may allow someone to break in and cause the pump to deliver too much or too little insulin to the patient
Equipment issue may allow someone to break in and cause the pump to deliver too much or too little insulin to the patient
FlexBurst360 therapy provides pain coverage across up to 6 areas of the trunk and/or limbs and enables adjustable programming.
The agency has issued proposed draft recommendations to guide incorporation of cybersecurity protections into medical devices at the time of manufacture.
Evoke is a novel, closed-loop SCS system that instantaneously reads, records, and responds to evoked compound action potentials.
The Senza SCS System is a neuromodulation device designed to deliver electrical stimulation using implantable leads and a rechargeable, implantable pulse generator.
Patients will be able to share information collected in the app with health care providers to provide a comprehensive assessment of the SCS or DRG therapy.
MPR highlights health innovations from the 2021 Consumer Electronics Show (CES).
NightWare is a smartwatch application that uses the Apple Watch and Apple iPhone platform.
The FDA has approved the Percept™ PC Deep Brain Stimulation (DBS) system (Medtronic) with BrainSense™ technology for neurological disorders.
The FDA has approved an expanded indication for the Infinity™ Deep Brain Stimulation (DBS) system (Abbott) to include targeting the internal globus pallidus, which may lead to symptom improvement in patients with Parkinson disease.